A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports

Overview of attention for article published in Drug Safety, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 40,547 followers.

RT @LawMedLegalRN: Yeeeeah, umm... A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Rep…

RT @BrianOverstreet: Very proud of @AdveraHealth team - validation study of our @US_FDA label change predictive algorithm published - http…

RT @BrianOverstreet: Very proud of @AdveraHealth team - validation study of our @US_FDA label change predictive algorithm published - http…

A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports. https://t.co/TKw6vbk2Tn

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.